Changchun Bcht Biotechnology Co. Class ASSE: 688276

Announcement on Voluntary Disclosure of Approval for Diphtheria, Tetanus, Pertussis (Acellular, Component) and Haemophilus Type b Conjugate Vaccine, Adsorbed

· Issued by Changchun Bcht Biotechnology Co. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Approval for Diphtheria, Tetanus, Pertussis (Acellular, Component) and Haemophilus Type b Conjugate Vaccine, Adsorbed

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment